Summary:
India achieved a 38% reduction in tuberculosis-related deaths between 2015 and 2025, exceeding the global decline of 35%, according to the WHO. The country’s TB mortality rate fell from 28 to 18 deaths per 100,000 people, while treatment success among drug-susceptible TB patients reached 94%. More than 250 million people have been covered under national screening programmes, supported by AI-enabled diagnostic tools, rapid molecular tests and the Ni-kshay digital platform. The government attributed this progress to early detection, improved diagnostics, nutritional assistance and increased community participation.
India recorded a 38% decline in tuberculosis (TB)-related deaths between 2015 and 2025, outperforming the global reduction of 35%, according to the World Health Organisation (WHO).
The country’s TB death rate dropped from 28 per 100,000 people in 2015 to 18 in 2025. Meanwhile, the treatment success rate among patients with drug-susceptible TB reached 94%.
India’s TB screening programmes have covered more than 250 million people, involving over 110 million chest X-rays and 30 million molecular diagnostic tests.
Health Minister Jagat Prakash Nadda credited this progress to wider access to early diagnosis, improved diagnostic technologies, nutritional support and greater involvement of communities.
Technology has further supported these efforts through AI-powered portable digital chest X-ray systems, rapid molecular testing methods and the Ni-kshay digital platform.







